Koyfin Home > Directory > Health Care > Horizon Therapeutics > Cash from Financing Activities

Horizon Therapeutics Cash from Financing Activities Chart (HZNP)

Horizon Therapeutics annual/quarterly Cash from Financing Activities from 2010 to 2020.
  • Horizon Therapeutics Cash from Financing Activities for the quarter ending September 09, 2020 was $920m a 98.65% increase of 907m year over year
  • Horizon Therapeutics Cash from Financing Activities for the last 12 months ending September 09, 2020 was $913m a 131.82% increase of 1,203m year over year
  • Horizon Therapeutics Annual Cash from Financing Activities for 2019 was $-290m a 94.29% decrease of -274m from 2018
  • Horizon Therapeutics Annual Cash from Financing Activities for 2018 was $-17m a 427.04% decrease of -71m from 2017
  • Horizon Therapeutics Annual Cash from Financing Activities for 2017 was $54m a -1,110.62% decrease of -603m from 2016
Other Cash Flow Metrics:
  • Horizon Therapeutics Cash Flow from Operations for the quarter ending December 12, 2018 was $109m a 155.94% increase of 170m year over year
  • Horizon Therapeutics Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $126m a 125.54% increase of 158m year over year
  • Horizon Therapeutics Total Revenue for the quarter ending December 12, 2018 was $356m a 37.03% increase of 132m year over year
View Chart On Koyfin

Quarterly HZNP Cash from Financing Activities Data

09/2020$920m
06/2020$20m
03/2020$-40m
12/2019$12m
09/2019$-64m
06/2019$-260m
03/2019$21m
12/2018$10m
09/2018$2m
06/2018$-24m

Annual HZNP Cash from Financing Activities Data

2019$-290m
2018$-17m
2017$54m
2016$657m
2015$1,442m
2014$338m
2013$67m
2012$164m
2011$55m
2010$30m